Canine Bone Marrow Mesenchymal Stem Cells

Canine bone marrow mesenchymal stem cells (cBM-MSCs) are multipotent adult stem cells residing in the bone marrow stroma. They are defined by their plastic adherence, fibroblast-like morphology, expression of characteristic surface markers (CD44+, CD90+, CD105+, and negativity for hematopoietic markers such as CD34- and CD45-), and trilineage differentiation capacity into osteocytes, chondrocytes, and adipocytes under defined inductive conditions.

cBM-MSCs have gained significant attention in both veterinary medicine and translational research. Unlike human MSCs, canine models offer the advantage of studying spontaneous, naturally occurring diseases - including osteoarthritis, intervertebral disc degeneration, and immune-mediated disorders - that closely mimic human pathologies. Key advantages of cBM-MSCs include: (1) robust expansion ex vivo - they can be isolated from small aspirates and expanded to clinically relevant numbers while retaining multipotency; (2) immunomodulatory properties - they suppress T-cell proliferation and secrete anti-inflammatory cytokines (IL-10, TGF-β), supporting their use in allogeneic transplantation; (3) functional cryopreservation - they maintain viability and potency after freeze-thaw cycles; (4) osteochondral competence - they reliably undergo chondrogenesis and osteogenesis, making them ideal for cartilage and bone repair studies; (5) species-relevant preclinical model - canine studies provide translationally valuable data for human regenerative medicine, particularly for large animal models and clinical trials.

Collectively, cBM-MSCs represent a reproducible, versatile, and clinically relevant cell source for investigating musculoskeletal regeneration, inflammatory diseases, and cell-based therapies, bridging the gap between rodent models and human applications.